GSK's settlement follows a $100 million deal by Sanofi earlier this year, reported by Bloomberg, which settled around 4,000 claims. The French drugmaker had rights to the OTC version of the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results